Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

RKH_Interactive_CV_show

136 views

Published on

  • Be the first to comment

  • Be the first to like this

RKH_Interactive_CV_show

  1. 1. Business Strategy Marketing and Sales Business Development and Acquisitions General Management Cross- Functional Leadership Richard Howell “Blue-sky” market projections Strategy and Commercial Assessment Revenue and Expense Modeling Strategic Planning New Product Planning Product Development Strategy Financial Planning Business Modeling Forecasting and Analytics Strategic | Results-Oriented | Cross-Functional Leader Brand Strategy Lifecycle Management / Brand protection Sales Promotion Agency Management Market analysis Market Research Insight and competitive intelligence research Product and sales training PR and Communications KOL development Mission/Vision Creation Team Building and Collaboration Project Management Team Leadership: International collaboration New Product Launch Matrix Management Issue Resolution Change management Resource Prioritization Internal and External Influence Cross-Functional Communication Marketing and sales excellence training Coaching Medical writing
  2. 2. Cross functional leadership • Mission/Vision Creation • Team Building and Collaboration • Project Management • International collaboration • New Product Launch
  3. 3. Business Strategy • Strategic Planning • New Product Planning • Product Development Strategy • Financial Planning • Business Modeling • Forecasting and Analytics
  4. 4. Marketing and Sales • Brand Strategy • Lifecycle Management / Brand protection • Sales Promotion • Agency Management • Market analysis • Market Research • Insight and competitive intelligence research • Product and sales training • PR and Communications • KOL development
  5. 5. Business Development and Acquisitions • “Blue-sky” market projections • Strategy and Commercial Assessment • Revenue and Expense Modeling
  6. 6. General Management • Matrix Management • Issue Resolution • Change management • Resource Prioritization • Internal and External Influence • Cross-Functional Communication • Marketing and sales excellence training • Coaching • Medical writing
  7. 7. Mission/Vision Creation • 4 letters – how hard can that be? • Futurology • “Turbocharge” T-cell immunosuppression • 2nd line Iressa vs docetaxel
  8. 8. Team Building and Collaboration • Certican “heavyweight” team – Collaboration as part of fast development team • Optimise MSDO marketing team – Team prioritization of product mix & support – Agreed fairness of workload / interest
  9. 9. Project Management • BIOGEN re-branding – Complex interaction of regulatory, logistics, IT, legal, artwork and component production – Global reach – Identified critical areas and those with accountability – Deliver first product Oct. 2015
  10. 10. International collaboration • Casodex global team – Country PM training and briefing – Organizing Wargames • Neoral brand protection team – Lectures on pharmacokinetics and generic product contamination in Iran and Taiwan
  11. 11. New Product Launch • Marketing lead Simulect and Certican Global launch teams • Marketing lead Iressa regional launch • Marketing lead global new product development – Xenotransplantation – Oncology (regional)
  12. 12. Brand Strategy • Simulect global launch • FTY 720 fingolimod in-license • Xenotransplantation • Sandoglobulin positioning • Opiate-receptor blockade • Certican global launch • Elidel psoriasis pre-launch • Casodex re-positioning
  13. 13. Lifecycle Management / Brand protection • Neoral team member • Cyclosporin brand protection in emerging markets • Casodex life cycle management plan
  14. 14. Sales Promotion • Sales representative UK • Specialist hospital sales UK • Sales force effectiveness trainer emerging markets • Extensive review of US promotional materials for compliance to FDA regulations (DMAC)
  15. 15. Agency Management • Briefing and managing agencies in: – UK – Canada – Switzerland – USA • Agency experience – Copy director “The Creative Edge” – Director Aerian Pharma Consulting LLC
  16. 16. Market analysis • Iressa global charitable drug access – Modelled potential impact of program – Based on GDP and population – Probability of patient access on corruption index • IMS medical indices “skunkworks” – Used relational data to identify market trends
  17. 17. Market Research • Briefing market research projects – Use and projected use IV immunoglobulin – Testing target product profiles • Insight research on: – ADHD – Osteoporosis
  18. 18. Insight and competitive intelligence research • CI on the following areas: – Colorectal cancer – Prostate cancer – Breast cancer – NSC lung cancer – NASH – MS – Glioblastoma – Osteoporosis – Neuro-psychopharmacy – Thrombosis
  19. 19. Product and sales training • Product training on cancer and immunology • Commissioned an “immunology lite” book • Wargames and positioning workshops
  20. 20. PR and Communications • Communications trained • Contributor to transplantation magazine • Project managed the “Prostate Line” website portal creation; from briefing to contents to selecting and managing vendors
  21. 21. KOL development • Identified KOLs in the UK, Canada and globally • Created “Immunology club” for UK clinical immunologists • Worked closely with KOLs to fine-tune their presentations • Interviewed KOLs for insight research
  22. 22. Strategic Planning • Developed strategy for re-launch of Sandoglobulin – Improved packaging with giving set – Focus on quality – Expand into off-label neutropaenias • Casodex – Unclear positioning – Developed clearer position and language
  23. 23. New Product Planning • Certican “heavyweight” team – Collaboration as part of fast development team • Optimise MSDO marketing team – Team prioritization of product mix & support – Agreed fairness of workload / interest
  24. 24. Product Development Strategy • Certican “heavyweight” team – Collaboration as part of fast development team • Optimise MSDO marketing team – Team prioritization of product mix & support – Agreed fairness of workload / interest
  25. 25. Financial Planning • Certican “heavyweight” team – Collaboration as part of fast development team • Optimise MSDO marketing team – Team prioritization of product mix & support – Agreed fairness of workload / interest
  26. 26. Business Modeling • Driver safety project – Re-presented as not just a safety issue but a productivity issue – Equated poor driving with increased costs and sales down-time – Poor driving correlation with poor sale performance – Modelled insurance data to show cost reduction from improving performance
  27. 27. Forecasting and Analytics • Developed Iressa launch forecasting model – Allowed use of population numbers to estimate market penetration – Valuable in countries with no aor suspect market research data • IMS medical indices – Used relational data to identify interesting correlations – Used these to drive hypotheses for primary research
  28. 28. “Blue-sky” market projections • Xenotransplantation – Created the Xenotransplantation launch and marketing plan • FTY 720 fingolomod – Marketing plans for transplantation and RA • CD3-immunotoxin – Marketing forecast and plans for tolerance induction
  29. 29. Strategy and Commercial Assessment • Marketing input to licensing teams • Input at MassConnect mentoring
  30. 30. Revenue and Expense Modeling • Launch forecasts for: – Iressa regional – Simulect and Certican global transplant – Certican RA – Matritech prostate cancer diagnostic – Veterinary use of novel compounds
  31. 31. Matrix Management • Certican “heavyweight” team – Collaboration as part of fast development team • Biogen re-brand – Identification of accountable and responsible parties – Agreement on deliverable and timelines
  32. 32. Issue Resolution • Swiss Biogen re-brand – CH had changed name and now faced a potential unable to supply situation – Worked with all parties to look for opportunities to streamline process – Obtained exceptions to operate outside of SOP • Calf serum potential contamination – Had to re-prioritize the global roll out of Simulect – Staggered launches and challenged country forecasts
  33. 33. Change management • Global drive safety program – Change management program – Needed to identify and influence all the affected parties • MSDO re-organization – Supported team members to help them find new jobs – Ensured all CVs up to date and offered practice interviews
  34. 34. Resource Prioritization • Mentor on “marketing powerhouse” training scheme • Trained brand managers on how to prioritize spend and time based on analysis of feasibility, speed, value and cost • Simplified the process for small markets
  35. 35. Internal and External Influence • Introduction of CD3 immunotoxin to Sandoz – Created opportunity for 3 way conversation between Sandoz, the NIH and Sir Roy Calne • Brand champion – Memorable and motivating presentations to sales forces and brand managers
  36. 36. Cross-Functional Communication • Wide experience in the industry means I have a high level of understanding of other departments’ rôles Marketing, clinical development, health and safety, packaging, logistics, regulatory etc.
  37. 37. Marketing and sales excellence training & Coaching • Coach / mentor on marketing excellence and sales force effectiveness programs at Novartis • Mentor at MassConnect
  38. 38. Medical writing • Wrote draft of Simulect pivotal paper – First fast track paper in “The Lancet” • Editor for pre-submission to oncology journals – Lancet Oncology – Anti-Cancer drugs – Journal of Clinical Oncology

×